Cargando…

Association of Cardiovascular and Metabolic Disease Genes with Psoriasis

Detalles Bibliográficos
Autores principales:	Lu, Yingchang, Chen, Haoyan, Nikamo, Pernilla, Low, Hui Qi, Helms, Cynthia, Seielstad, Mark, Liu, Jianjun, Bowcock, Anne M., Stahle, Mona, Liao, Wilson
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570714/ https://www.ncbi.nlm.nih.gov/pubmed/23190900 http://dx.doi.org/10.1038/jid.2012.366

Ejemplares similares

Meta-Analysis of the TNFAIP3 Region in Psoriasis Reveals a Risk Haplotype that is Distinct from Other Autoimmune Diseases
por: Nititham, Joanne, et al.
Publicado: (2014)

Genetic Association with ERAP1 in Psoriasis Is Confined to Disease Onset after Puberty and Not Dependent on HLA-C*06
por: Lysell, Josefin, et al.
Publicado: (2013)

A Genetic Risk Score Combining Ten Psoriasis Risk Loci Improves Disease Prediction
por: Chen, Haoyan, et al.
Publicado: (2011)

The prevalence of ADH1B and OPRM1 alleles predisposing for alcohol consumption are increased in the Hungarian psoriasis population
por: Szentkereszty-Kovács, Zita, et al.
Publicado: (2019)

The Role of 39 Psoriasis Risk Variants on Age of Psoriasis Onset
por: Lu, Yingchang, et al.
Publicado: (2013)

Accelerating Translational Research by Clinically Driven Development of an Informatics Platform–A Case Study
por: Abugessaisa, Imad, et al.
Publicado: (2014)

Risk of respiratory infection in patients with plaque psoriasis
por: Svedbom, Axel, et al.
Publicado: (2021)

Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility
por: Yin, Xianyong, et al.
Publicado: (2015)

Interleukin-17 and - 23 Inhibitors Associated with Direct Effects on Depressive Symptoms in Psoriasis: A Register Study
por: SVEDBOM, Axel, et al.
Publicado: (2023)

Protective Effect of Human Endogenous Retrovirus K dUTPase Variants on Psoriasis Susceptibility
por: Lai, Olivia Y., et al.
Publicado: (2012)

HLA-Cw*0602 associates with a twofold higher prevalence of positive streptococcal throat swab at the onset of psoriasis: a case control study
por: Mallbris, Lotus, et al.
Publicado: (2009)

A Genome-Wide Association Study of Psoriasis and Psoriatic Arthritis Identifies New Disease Loci
por: Liu, Ying, et al.
Publicado: (2008)

Association analysis identifies ZNF750 regulatory variants in psoriasis
por: Birnbaum, Ramon Y, et al.
Publicado: (2011)

Cardiovascular and Metabolic Diseases Comorbid with Psoriasis: Beyond the Skin
por: Furue, Masutaka, et al.
Publicado: (2017)

Psoriasis Patients Are Enriched for Genetic Variants That Protect against HIV-1 Disease
por: Chen, Haoyan, et al.
Publicado: (2012)

Circulating levels of sphingosine-1-phosphate are elevated in severe, but not mild psoriasis and are unresponsive to anti-TNF-α treatment
por: Checa, Antonio, et al.
Publicado: (2015)

IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications
por: von Stebut, Esther, et al.
Publicado: (2020)

MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis?
por: Sonkoly, Enikö, et al.
Publicado: (2007)

CARDIOVASCULAR COMORBIDITIY IN PSORIASIS
por: Singh, Gurcharan, et al.
Publicado: (2011)

Analysis of Cardiovascular Risk Factors and Metabolic Syndrome in Korean Patients with Psoriasis
por: Kim, Gun-Wook, et al.
Publicado: (2012)

Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review
por: Marani, Andrea, et al.
Publicado: (2022)

Serious infections in patients with self-reported psoriatic arthritis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) treated with biologics
por: Ritchlin, Christopher T., et al.
Publicado: (2019)

Cardiovascular findings in patients with psoriasis
por: Öztürkcan, Serap, et al.
Publicado: (2006)

Cardiovascular comorbidities in psoriasis (Review)
por: Branisteanu, Daciana Elena, et al.
Publicado: (2022)

Pathway-based analysis using reduced gene subsets in genome-wide association studies
por: Zhao, Jingyuan, et al.
Publicado: (2011)

A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17
por: Armstrong, April W., et al.
Publicado: (2022)

A Review of Psoriasis, a Known Risk Factor for Cardiovascular Disease and Its Impact on Folate and Homocysteine Metabolism
por: McDonald, Ian, et al.
Publicado: (2012)

HIV, Stigma, and Rates of Infection: Absence of Evidence
por: Seielstad, Mark
Publicado: (2007)

Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis
por: Wu, J.J., et al.
Publicado: (2022)

Psoriasis and Metabolic Syndrome
por: Malkic Salihbegovic, Eldina, et al.
Publicado: (2015)

LC–MS Metabolomics of Psoriasis Patients Reveals Disease Severity-Dependent Increases in Circulating Amino Acids That Are Ameliorated by Anti-TNFα Treatment
por: Kamleh, Muhammad Anas, et al.
Publicado: (2014)

Psoriasis & cardiovascular morbidity: The missing links?
por: Ganguly, Satyaki, et al.
Publicado: (2017)

The Association Between Psoriasis and Cardiovascular Diseases
por: Zwain, Ahmed, et al.
Publicado: (2021)

CRY2 Is Associated with Rapid Cycling in Bipolar Disorder Patients
por: Sjöholm, Louise K., et al.
Publicado: (2010)

Metabolic profiling reveals interleukin-17A monoclonal antibody treatment ameliorate lipids metabolism with the potentiality to reduce cardiovascular risk in psoriasis patients
por: Cao, Han, et al.
Publicado: (2021)

Genomewide Scan Reveals Association of Psoriasis with IL-23 and NF-κB Pathways
por: Nair, Rajan P., et al.
Publicado: (2009)

Access to, use, knowledge, and preferences for information technology and technical equipment among people with chronic obstructive pulmonary disease (COPD) in Sweden. A cross-sectional survey study
por: Sönnerfors, Pernilla, et al.
Publicado: (2021)

Polyamine Metabolism Changes in Psoriasis
por: Broshtilova, Valentina, et al.
Publicado: (2013)

Metabolic comorbidities of psoriasis (Review)
por: Branisteanu, Daciana Elena, et al.
Publicado: (2022)

Real-World Experience of Patient-Relevant Benefits and Treatment Satisfaction with Apremilast in Patients with Psoriasis: An Analysis of the APPRECIATE Study
por: Klein, Toni Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2fd8o0fgqdnspkp2hsil1poiob